Leuprolide Acetate Injection
| General Information: Leuprolide acetate injection is typically utilized in the pallative treatment of advanced prostatic cancer. |
| |
| Manufacturer |
Products |
Size |
NDC |
PI |
MSDS |
| TEVA |
Leuprolide |
1 mg/0.2 mL
2.8mL |
00703-4014-18 |
PI |
MSDS |
| |
|
|
|
|
|
| Caraco |
Leuprolide |
1mg/0.2mL 2.8mL |
41616-0936-40 |
PI |
MSDS |
|
| |
| Clinical Data:
For any questions or for further
information related to Leuprolide Acetate Injection,
clinical pharmacology, additional indications and
usages, contraindications,
warnings, precautions, adverse
reactions, dosage,
administration and/or storage
of this product, please
contact
BDI Pharma or
call
1-800-948-9834. |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|